Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients

Affiliations

• ¹ Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ, USA.
• ² Dignity Health Cancer Institute, Phoenix, AZ, USA.
• ³ Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ, USA.
• ⁴ Translational Medicine, Adaptive Biotechnologies, Seattle, WA, USA.
• ⁵ Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, AZ, USA.
• ⁶ Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
• ⁷ Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ, USA. fonseca.rafael@mayo.edu.